1-2 of 2
In Duk Jung
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer

Yeongseon Byeon, Jeong-Won Lee, Whan Soo Choi, Ji Eun Won, Ga Hee Kim, Min Gi Kim, Tae In Wi, Jae Myeong Lee, Tae Heung Kang, In Duk Jung, Young-Jae Cho, Hyung Jun Ahn, Byung Cheol Shin, Young Joo Lee, Anil K. Sood, Hee Dong Han, Yeong-Min Park
Journal: Cancer Research
Series: Author Choice
Cancer Res (2018) 78 (21): 6247–6256.
https://doi.org/10.1158/0008-5472.CAN-17-3871
Published: 01 November 2018
View article titled, CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer
Open the PDF for CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Enhanced Efficacy of Therapeutic Cancer Vaccines Produced by Co-Treatment with Mycobacterium tuberculosis Heparin-Binding Hemagglutinin, a Novel TLR4 Agonist

In Duk Jung, Soo Kyung Jeong, Chang-Min Lee, Kyung Tae Noh, Deok Rim Heo, Yong Kyoo Shin, Cheol-Heui Yun, Won-Jung Koh, Shizuo Akira, Jake Whang, Hwa-Jung Kim, Won Sun Park, Sung Jae Shin, Yeong-Min Park
Journal: Cancer Research
Cancer Res (2011) 71 (8): 2858–2870.
https://doi.org/10.1158/0008-5472.CAN-10-3487
Published: 13 April 2011
View article titled, Enhanced Efficacy of Therapeutic Cancer Vaccines Produced by Co-Treatment with <em>Mycobacterium tuberculosis</em> Heparin-Binding Hemagglutinin, a Novel TLR4 Agonist
Open the PDF for Enhanced Efficacy of Therapeutic Cancer Vaccines Produced by Co-Treatment with <em>Mycobacterium tuberculosis</em> Heparin-Binding Hemagglutinin, a Novel TLR4 Agonist in another window
Includes: Supplementary data